Page last updated: 2024-09-05

latrepirdine and Parkinsonian Disorders

latrepirdine has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cano-Cuenca, N; Jordán, J; Solís-García del Pozo, J	1

Reviews

1 review(s) available for latrepirdine and Parkinsonian Disorders

Article	Year
[Latrepirdine: a systematic review of the preclinical studies]. Revista de neurologia, 2015, Jan-01, Volume: 60, Issue:1 Topics: Animals; Biological Availability; Calcium Signaling; Cholinesterase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Humans; Indoles; Mice; Mitochondria; Molecular Structure; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Protein Aggregation, Pathological; Rabbits; Rats; Receptors, N-Methyl-D-Aspartate; Tissue Distribution	2015

Article

Year

[Latrepirdine: a systematic review of the preclinical studies].

Revista de neurologia, 2015, Jan-01, Volume: 60, Issue:1

Topics: Animals; Biological Availability; Calcium Signaling; Cholinesterase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Humans; Indoles; Mice; Mitochondria; Molecular Structure; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Protein Aggregation, Pathological; Rabbits; Rats; Receptors, N-Methyl-D-Aspartate; Tissue Distribution

2015